Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹20,153 Cr
Revenue (TTM)
₹5,621 Cr
Net Profit (TTM)
₹670 Cr
ROE
19.9 %
ROCE
25.4 %
P/E Ratio
30.1
P/B Ratio
6.3
Industry P/E
28.32
EV/EBITDA
21
Div. Yield
2.8 %
Debt to Equity
0
Book Value
₹716.3
EPS
₹149.2
Face value
10
Shares outstanding
44,942,092
CFO
₹4,309.00 Cr
EBITDA
₹6,634.10 Cr
Net Profit
₹4,922.90 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bayer Cropscience
| -1.6 | -5.6 | 3.1 | -7.0 | 4.0 | -2.7 | 2.3 |
|
BSE Commodities
| -2.3 | -5.5 | 0.6 | 12.2 | 16.1 | 13.6 | 16.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bayer Cropscience
| -17.5 | 0.9 | 12.4 | -0.6 | -8.7 | 50.4 | -15.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bayer Cropscience
|
4,485.8 | 20,152.9 | 5,620.6 | 670.4 | 13.4 | 22.4 | 30.1 | 6.3 |
| 192.2 | 2,491.6 | 500.5 | 13.2 | 5.5 | 1.9 | 188.5 | 3.6 | |
| 1,338.1 | 2,223.2 | 1,240.4 | 132.3 | 13.1 | 12.2 | 16.8 | 1.8 | |
| 1,004.5 | 4,526.1 | 1,978.5 | 265.0 | 16.3 | 18 | 17.1 | 2.9 | |
| 137.3 | 1,585.2 | 998.2 | 111.0 | 14.3 | 12 | 14.3 | 1.6 | |
| 580.6 | 1,687.8 | 2,072.7 | 140.8 | 9.5 | 12.4 | 11.9 | 1.4 | |
| 127.0 | 2,970.8 | 1,424.9 | -44.7 | -1.1 | -13.7 | -- | 4.3 | |
| 244.4 | 4,738.2 | 2,871.0 | 167.0 | 7.8 | 11.7 | 28.4 | 2.3 | |
| 1,011.5 | 9,139.8 | 5,031.2 | 565.9 | 9.9 | 21.9 | 16.2 | 3.2 | |
| 389.3 | 19,374.3 | 3,234.0 | 531.4 | 18.3 | 17.8 | 36.5 | 5.9 |
Indian chemical sector hits a rough patch
2 min read•By Hemkesh Khattar
1 min read•By Rajan Gulati
Companies that club industry profits
2 min read•By Mohammed Ekramul Haque
Companies operating with wide margins
2 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines... primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India. Read more
Incorporated
1958
Chairman
Pankaj Patel
Managing Director
Simon Thorsten Wiebusch
Group
Bayer Crop - MNC
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Bayer CropScience Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Bayer CropScience Ltd is ₹4,485.80 (NSE) and ₹4,484.20 (BSE) as of 18-Mar-2026 IST. Bayer CropScience Ltd has given a return of 4% in the last 3 years.
The P/E ratio of Bayer CropScience Ltd is 30.06 times as on 18-Mar-2026, a 6 premium to its peers’ median range of 28.32 times.
The P/B ratio of Bayer CropScience Ltd is 6.26 times as on 18-Mar-2026, a 101 premium to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
38.95
|
7.76
|
|
2024
|
31.79
|
8.26
|
|
2023
|
23.97
|
6.70
|
|
2022
|
34.67
|
8.86
|
|
2021
|
48.31
|
9.34
|
The 52-week high and low of Bayer CropScience Ltd are Rs 6,511.00 and Rs 4,273.00 as of 19-Mar-2026.
Bayer CropScience Ltd has a market capitalisation of ₹ 20,153 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bayer CropScience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.80
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.